Chemoinformaics analysis of 9,19-cyclolanost-24-en-3-ol, acetate, (3beta)-
Molecular Weight | 468.766 | nRot | 5 |
Heavy Atom Molecular Weight | 416.35 | nRig | 24 |
Exact Molecular Weight | 468.397 | nRing | 5 |
Solubility: LogS | -7.018 | nHRing | 0 |
Solubility: LogP | 7.813 | No. of Aliphatic Rings | 5 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
Atoms Count | 86 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 5 |
No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 32 | No. of Saturated Rings | 5 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 89.7172 |
nHD | 0 | BPOL | 54.7708 |
QED | 0.298 |
Synth | 5.398 |
Natural Product Likeliness | 3.181 |
NR-PPAR-gamma | 0.259 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.007 |
Pgp-sub | 0 |
HIA | 0.013 |
CACO-2 | -4.948 |
MDCK | 0.000011 |
BBB | 0.211 |
PPB | 1.00079 |
VDSS | 1.843 |
FU | 0.0158963 |
CYP1A2-inh | 0.022 |
CYP1A2-sub | 0.201 |
CYP2c19-inh | 0.071 |
CYP2c19-sub | 0.948 |
CYP2c9-inh | 0.087 |
CYP2c9-sub | 0.413 |
CYP2d6-inh | 0.043 |
CYP2d6-sub | 0.208 |
CYP3a4-inh | 0.271 |
CYP3a4-sub | 0.496 |
CL | 11.223 |
T12 | 0.007 |
hERG | 0.186 |
Ames | 0.013 |
ROA | 0.065 |
SkinSen | 0.223 |
Carcinogencity | 0.02 |
EI | 0.074 |
Respiratory | 0.842 |
NR-Aromatase | 0.307 |
Antiviral | No |
Prediction | 0.542402 |